Predicting the Post-Thrombotic Syndrome: Not Quite Ready for Prime Time

Geoffrey D. Barnes

doi:10.1055/s-0038-1667034

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2018; 118(08): 1345-1346
DOI: 10.1055/s-0038-1667034

Invited Editorial Focus

Georg Thieme Verlag KG Stuttgart · New York

Predicting the Post-Thrombotic Syndrome: Not Quite Ready for Prime Time

Geoffrey D. Barnes

¹Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, Michigan, United States

› Author Affiliations

Abstract

Full Text

References

References
1 Schulman S, Ageno W, Konstantinides SV. Venous thromboembolism: past, present and future. Thromb Haemost 2017; 117 (07) 1219-1229
2 Wik HS, Ghanima W, Sandset PM, Kahn SR. Scoring systems for postthrombotic syndrome. Semin Thromb Hemost 2017; 43 (05) 500-504
3 Méan M, Limacher A, Alatri A, Aujesky D, Mazzolai L. Derivation and validation of a prediction model for risk stratification of postthrombotic syndrome in elderly patients with deep vein thrombosis. Thromb Haemost 2017; 117 (08) 1419-1427
4 Villalta S, Bagatella P, Picolli A. , et al. Assessment of validity and reproducibility of a clinical scale for the post thrombotic syndrome. Haemostasis 1994; 1994 (24) 158a
5 Kahn SR, Shapiro S, Wells PS. , et al; SOX trial investigators. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 2014; 383 (9920): 880-888
6 Vedantham S, Goldhaber SZ, Julian JA. , et al; ATTRACT Trial Investigators. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017; 377 (23) 2240-2252
7 Rabinovich A, Ducruet T, Kahn SR. ; SOX Trial investigators. Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis. J Thromb Haemost 2018; 16 (02) 262-270
8 Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137 (02) 263-272
9 Larsen TB, Lip GY, Skjøth F, Due KM, Overvad K, Hvilsted Rasmussen L. Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study. Circ Cardiovasc Qual Outcomes 2012; 5 (03) 335-342
10 Vedantham S, Kahn SR, Goldhaber SZ. , et al. Endovascular therapy for advanced post-thrombotic syndrome: proceedings from a multidisciplinary consensus panel. Vasc Med 2016; 21 (04) 400-407
11 Utne KK, Ghanima W, Foyn S, Kahn S, Sandset PM, Wik HS. Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome. Thromb Haemost 2016; 115 (02) 361-367
12 Lubberts B, Paulino Pereira NR, Kabrhel C, Kuter DJ, DiGiovanni CW. What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis. Thromb Haemost 2016; 116 (03) 417-431